Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery

Recruiting now · Not applicable

Conditions studied: Morbid Obesity, Bariatric Surgery Candidate

In brief

Rivaroxaban versus enoxaparin for prophylaxis of venous thromboembolism in morbidly obese patients undergoing bariatric surgery: An open\_label randomized controlled trial

Key facts

Study ID

NCT06689241

Run by

Alexandria University

People needed

162

Starts

2024-10-01

Expected to finish

2026-05-01

Last updated by the study team

2025-04-22

Who can join

Age: 20 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age: 20-60 years, both sexes.
• ASA physical status class I to III.
• BMI 35-50 kg/m²

You may not qualify if…

• Severe cardiac disorder
• chronic renal failure
• liver cirrhosis
• major psychological disorder

Where it is running

• Alexandria University — Alexandria, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.